deltatrials
Terminated PHASE2 INTERVENTIONAL 3-arm NCT00807209

Dose Finding Posterolateral Thoracotomy Study

A Phase 2 Open-Label, Parallel Group, Randomized, Dose-Finding Study to Assess the Efficacy and Safety of Intercostal SKY0402 in Subjects Undergoing Posterolateral Thoracotomy

Sponsor: Pacira Pharmaceuticals, Inc

Conditions Postoperative Pain
Interventions Bupivacaine via epidural Fentanyl via PCA High Dose SKY0402 Low Dose SKY0402 Placebo
Updated 9 times since 2017 Last updated: Apr 15, 2012 Started: Dec 31, 2008 Primary completion: Feb 28, 2009 Completion: Feb 28, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor decision unrelated to safety

Other terminated trials from Pacira Pharmaceuticals, Inc

More terminations from Pacira Pharmaceuticals, Inc

Other Postoperative Pain trials with similar outcome

Browse all Postoperative Pain trials

Listed as NCT00807209, this PHASE2 trial focuses on Postoperative Pain and remains terminated or withdrawn. Sponsored by Pacira Pharmaceuticals, Inc, it has been updated 9 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 20 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 4 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE2

  2. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  3. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE2

    First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pacira Pharmaceuticals, Inc
Data source: Pacira Pharmaceuticals, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations